Due: July 11, 2025
The Joint Science and Technology Office (JSTO) within the Defense Threat Reduction Agency (DTRA) is charged with addressing the potential threat to the armed services posed by a wide range of bacterial, viral and toxin agents. The current technology and animal use and care guidelines limit the number of blood samples that can be taken in the period between vaccine administration and the fully developed immunological response. The objective of this project is to identify and develop technologies that can expand the range of in vivo micro sampling to comprehensively assess the extended developmental immune response to vaccination. These nascent technologies are expected to allow increased or continuous in vivo micro sampling and in parallel utilize detection technologies that can characterize post-vaccination immune maturation in small samples.
Responding to this opportunity requires membership in the Medical CBRN Defense Consortium. This Consortium releases numerous solicitations throughout the year, so even if this opportunity may not end up being right for you, we strongly encourage you to join, so you are ready for the next opportunity.
Complete the form below and a program representative will reach out to you shortly to support you through the process.